-
Paxlovid: Is Africa Ready For The New Phase Of Covid-19 Treatment?
In November 2021, a mid-to-late stage study showed that an antiviral medication was nearly 90% effective in preventing hospitalisations and deaths in adults at high risk of severe illness. By December, the Paxlovid was cleared for Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) in America and is now used to treat…
-
US Researchers Offer Solution To Vaccine Inequality
Two years into the coronavirus pandemic and several variants later, the world is still struggling to vaccinate more than half of its population. Public health experts record that over 10 billion covid-19 vaccine doses have been produced since mid-2020, but more than 70 percent of the vaccines produced were consumed by wealthy nations. For instance,…